CICigna
Price
-2.2%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality strong, nothing alarming, price roughly fair, growth steady, the market undecided.
The Cigna Group®, together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"), is a global health company.
In the company’s own words · 10-K filed Feb 26, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Cigna (CI) reported revenue of $71.7B in Q2 2026 (quarter ended Jun 30, 2026), up 6.7% from the same quarter a year earlier. That came with a gross margin of 21% and net income of $1.88B (2.6% of revenue). For the full year FY2025, revenue was $274.9B (+11% year on year) and net income $6.29B. Its largest product in Q2 2026 was Network Pharmacy at $33.3B, 50% of the disclosed total, ahead of Home Delivery And Specialty at 31%. The next results filing is expected around Oct 29, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 30, 2026The Cigna Group Hosts 2026 Investor Day;.Regulation FD disclosure · press release
- Jul 30, 2026The Cigna Group Reports Strong Second Quarter 2026 Results, Raises 2026 Outlook.Earnings release · press release
- Apr 30, 2026The Cigna Group Reports Strong First Quarter 2026 Results, Raises 2026 Outlook.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Q2 2026 · $66.13BThe company’s own SEC segment disclosure.
- Network Pharmacy$33.33B50%
- Home Delivery And Specialty$20.44B31%
- Service$4.37B7%
- Service Fees And Other$3.96B6%
- Other Pharmacy$3.72B6%
- Service Other$315.0M0%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.